Health
New genetically encoded sensor helps detect drugs of abuse – News-Medical.net
A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the…
A genetically encoded sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell.
Compounds related to psychedelic drugs such as LSD and dimethyltryptamine (DMT) show great promise for treating disorders such as depression, post-traumatic stress…
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
General9 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News15 hours agoSenior constable injured in crash between unmarked police car and stolen vehicle in Pimpama, Queensland
-
Business24 hours ago3 US dividend stocks that can boost an ASX retirement portfolio